| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9959716 | Journal of the American College of Cardiology | 2005 | 8 Pages |
Abstract
Almost one-half of patients with CAD hospitalized for HF in the U.S. are not treated with aspirin. This study found no evidence of harm from aspirin in this population and suggests a treatment benefit. Withholding aspirin based upon theoretical concerns about adverse effects appears to be unjustified.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Frederick A. (FACC), Pam MA, MS, Edward P. (FACC), Saif S. MPH, JoAnne M. MD, Harlan M. (FACC),